Evidence map›Paper›PMID 42151529›Full record

ArticleJournal of human genetics2026

Further delineation of the phenotype and genotype in a newly identified PAN2-related disorder.

Erdem Kındış, Elif Eviz, Serdar Ceylaner

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of human genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Erdem KındışMedical Genetics Clinic, Şanlıurfa Training and Research Hospital, Şanlıurfa, Türkiye. erdem9217@gmail.com.ORCID http://orcid.org/0000-0003-1416-7920
Elif EvizPediatric Endocrinology Clinic, Şanlıurfa Training and Research Hospital, Şanlıurfa, Türkiye.ORCID http://orcid.org/0000-0002-8889-6811
Serdar CeylanerIntergen Genetic and Rare Diseases Diagnosis and Research Diagnosis, Ankara, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Regulation of mRNA decay is a critical mechanism for effective gene expression. Poly(A) tail length is directly associated with mRNA stability, and deadenylation, which shortens poly(A) tails, plays a central role in mRNA regulation. PAN2 encodes a key component of the deadenylation machinery. Recently, loss-of-function variants in PAN2 have been associated with neurodevelopmental delay and multiple congenital anomalies in seven patients from five unrelated families. Here, we report two siblings presenting with neurodevelopmental delay and multiple congenital anomalies consistent with previously described PAN2-related cases. Notably, both siblings also exhibited esophageal atresia (EA) and developmental dysplasia of the hip (DDH). Whole-exome sequencing (WES) in the older sibling identified a novel homozygous nonsense variant in PAN2, c.1432C>T (p.Arg478Ter). Segregation analysis confirmed homozygosity in the affected sibling, remaining family members were carrier. This study expands the genotypic spectrum of PAN2-related disorder and suggests additional clinical features contributing to this newly emerging disorder.

Indexed as

Abnormalities, MultipleExoribonucleasesGenetic Association StudiesPhenotypeAdolescentChildCodon, NonsenseExome SequencingGenotypeHomozygoteHumansMalePedigreeSiblingsCodon, NonsenseExoribonucleases

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.